Areas of expertise looked for:
Spin-offs creation, Investment analysis, Asset selection, Technology assessment
Inserm Transfert Initiative is the seed investment company of Inserm, the french public institution entirely devoted to biological, medical and public health research. Inserm Transfert Initiative is focused on seed investment and consist of four major actors in the financing of biotech start-ups: Inserm Transfert SA, CDC Enterprises, Natixis Venture Capital and Sofinnova Partners.
Inserm Transfert Initiative supports biotech company founders during their first steps.
Name: Coutet Matthieu
Function: Managing partner
Address: 7 rue watt 75013 Paris, France
Phone: +331 55 03 01 16